The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Our Commitment to Research

Our Commitment to Research

August 1, 2010 • By Stanley B. Cohen, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Stanley B. Cohen, MD

Rheumatic diseases are a major burden to the health of the U.S. population, causing substantial disability and taxing the limited resources of our current healthcare system—and exponential growth in the numbers of patients with chronic musculoskeletal disease is projected in the near future. There is a growing need for new clinical and pharmacological interventions to treat people with these conditions, most of whom receive their care from ACR members. Rheumatologists and rheumatology health professionals are dedicated to healing, preventing disability, and one day curing the more than 100 types of arthritis, and we must continue to support research to increase our ability to provide care for our patients.

You Might Also Like
  • Without You, ACR REF Wouldn’t Be Here
  • REF’s Campaign to Support RA Research Nears its Initial Funding Target
  • REF and AF Partner to Provide an Additional “Bridge Funding”
Explore This Issue
August 2010
Also By This Author
  • The Workforce Today & Tomorrow

The ACR continues to promote basic, clinical, and health services research in rheumatic and musculoskeletal diseases, which will translate into improvements in the care and clinical outcomes of patients. The ACR supports research and education through our professional meetings series, the publication of our journals, advocacy for increased funding for rheumatology research, and collaboration with the ACR Research and Education Foundation (REF). The ACR Committee on Research is charged with determining the emerging research priorities of our organization and developing a research agenda that comprehensively addresses the important rheumatic disease research areas. This agenda focuses on new technologies, infrastructure, and funding opportunities. The development of the Rheumatology Clinical Registry is one example of a technology innovation. This clinical data management tool is aimed at improving care and drug safety for patients with rheumatoid arthritis (RA), osteoarthritis, osteoporosis, and gout. The ARHP also has a research committee with a strong emphasis on support for new and established researchers. In the coming year, these committees will be revising the ACR’s research agenda to meet the needs of our research community.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

More Support for Scientific Programs

The ACR works closely with the National Institutes of Health (NIH) to support strong scientific programs that will improve the health of patients with rheumatic diseases. Each year, ACR, REF, and ARHP leadership convene face-to-face meetings with senior staff of different NIH institutes and centers to discuss ways to work together to take maximal advantage of funding opportunities for our academic researchers. This year’s meetings have focused on strengthening the relationship between the ACR and NIH, including discussions about the ACR’s research agenda, progress made with the REF’s Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign, and ways to facilitate an exchange of ideas on current and future funding opportunities.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, President's Perspective, Rheumatoid Arthritis Tagged With: AC&R, Basic research, Clinical research, National Institutes of Health, NIH, REF News, rheumatic diseases, Rheumatoid arthritisIssue: August 2010

You Might Also Like:
  • Without You, ACR REF Wouldn’t Be Here
  • REF’s Campaign to Support RA Research Nears its Initial Funding Target
  • REF and AF Partner to Provide an Additional “Bridge Funding”
  • Unique Meeting Accelerates RA Research

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)